Bøger om Novo

Louise Hansen er bogens praktiserende læge, hun har mange patienter, men ikke tid nok.Danskerne er efterhånden gode til at blive gamle, high five, men det øger presset på sundhedsvæsenet. Derfor skal vi blive bedre til at udnytte teknologi til at løfte opgaver fra lægen over på patienten selv.Hvad hvis vi bad fremtidens patient om selv at undersøge sin urin for bakterier, pode for halsbetændelse, måle blodtryk, hjerterytme og iltning af blodet? Ville det betyde dårligere behandling? Nej, tværtimod.Smartphones, apps, puls-ure og kunstig intelligens er fremtidens nyttige værktøjer i lægetasken – og de kan forbedre behandlingen, befolkningssundheden og lægens arbejdsvilkår. De to læger Andreas Pihl og Michael Hejmadi giver et underholdende kig ind i den almene lægepraksis, hvor både sundhedsvæsenet og den praktiserende læge er sat skakmat af dumme systemer og forældede organisationer.

In their 100th year of doing business, and more than twenty years after his retirement as CEO, Novo Nordisk still practices the leadership principles formulated by Mads Øvlisen. This elite practice of leadership - which he calls ‘heartcore’ - originated in Danish culture, and still continues to create success globally. This book is written to be a source of inspiration for all leaders who aim at fostering a better world.Mads Øvlisen delves deep into his thoughts on leadership, which have contributed to making Novo Nordisk one of the world’s leading companies. ‘Heartcore’ is a leadership practice that fosters extraordinary growth and renewal by setting high standards for mutual respect, creativity, talent, and freedom. He outlines how one can meet greater targets by balancing ‘soft’ values with hard results, and by creating an equilibrium between expected economic surplus, social responsibility, and environmental quality.Mads Øvlisen was the CEO of Novo Nordisk from 1981 to 2000, and after retiring, he continued as chairman of the board until 2006. He has simultaneously held board positions in a handful of corporations, among others, LEGO and the Royal Theatre. Mads has been

Today Novo Nordisk is Denmark’s largest industrial enterprise and one of the most highly valued companies in the world. The company is a global leader in pharmaceuticals for the treatment of diabetes, hemophilia disorders, and obesity, and it has positioned itself at the forefront with re-gard to social responsibility, environmental protection, and sustainability.For the first time, this book tells the whole story of a basement business that was built into a global pharmaceutical company. It all began in 1922, when insulin came to Denmark and inspired the es-tablishment of two companies, Nordisk Insulinlaboratorium and Novo Terapeutisk Laboratorium. After many years of fierce rivalry, the two companies merged in 1989 in order to be able to survive in global competition. Soon after, years of merger negotiations brought Novo Nordisk to the brink of moving out of Denmark.The story of Novo Nordisk is a story of groundbreaking research and big bets but also of setbacks and crises. A story of strong leaders and personalities but also of family struggles and company infighting. The book is based on full and unhindered access to the company’s archives.